Bioasis Technologies (BIOAF) Stock Price

Bioasis Technologies Price

OTC·CLOSED
0.00
​
Market closed

Revenue at Bioasis Technologies has contracted by 31.6% per year over the past 6 years to 37,700.00 CAD. Bioasis Technologies's net margin stands at -7,851.7%, down from -899.9% several years earlier.

Bioasis Technologies stock price

Access this data via the Eulerpool API

Bioasis Technologies business model & stock analysis

biOasis Technologies, Inc. operates as a biopharmaceutical company. The company is headquartered in Burnaby, British Columbia. The company went IPO on 2007-07-24. The firm is engaged in the development of the xB3 platform, a technology for the delivery of therapeutics across the blood brain barrier (BBB) and the treatment of central nervous system (CNS) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. xB3 is based on a human transport protein found circulating at low levels in the blood. The xB3 platform has an efficacy in its ability to shuttle molecules across the blood-brain barrier and reach its targets within the brain through a process called receptor-mediated transcytosis. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

Frequently asked questions about Bioasis Technologies

Converted at the current exchange rate, the Bioasis Technologies share trades at 0.00 EUR (0.00 CAD).

The Bioasis Technologies share (BIOAF) is listed on 4 stock exchanges, including: Toronto (BTI.V), Frankfurt (107.F), München (107.MU).

The revenue cannot currently be calculated for Bioasis Technologies.

The profit cannot currently be calculated for Bioasis Technologies.

The P/E ratio cannot be calculated for Bioasis Technologies at the moment.

The P/S cannot be calculated for Bioasis Technologies currently.

The Eulerpool Quality Score for Bioasis Technologies is 2/10.

The ISIN of Bioasis Technologies is CA09064N1033. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Bioasis Technologies is A1KCZ1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Bioasis Technologies is BIOAF. The ticker symbol is used to trade Bioasis Technologies shares on the stock exchange.

Fair ValueTerminal
0.00 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website bioasis.us
Country
Currency
CAD
Initial public offering
Jul 24, 2007
ISIN
CA09064N1033
Cusip
09064N103
Market capitalization
11,295.45 CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2023
-0.00
P/Ee 2024
-0.00
P/Ee 2025
-0.00
P/S
P/Se
0.08
EV/EBIT
—
P/B Ratio
0.03
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
18,975.00 %
Last updated Oct 9, 2026, 11:06 AM

Bioasis Technologies Peer Group

Bioasis Technologies Ticker

FRANKFURT · 107.FMUNICH · 107.MUOTC · BIOAFTSX · BTI.V

Bioasis Technologies FIGI

BTI:CN · BBG000RF42R8BTI:CV · BBG000RF43J5BTI:CJ · BBG000RF44B1BTI:TV · BBG000RF45Q2BTI:TN · BBG000RF4699BTI:TG · BBG000RF46R9BTI:TK · BBG000RF4724BIOAF:US · BBG000VNSWG6BIOAF:UV · BBG000VNSZF0BTI:TW · BBG001QLHZF0BTI:DV · BBG003G889F4BTI:DS · BBG004J9X754